Mircette: Reliable Low-Dose Estrogen and Progestin Contraception
| Product dosage: 15mcg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 56 | $1.15 | $64.50 (0%) | 🛒 Add to cart |
| 84 | $0.94 | $96.75 $79.12 (18%) | 🛒 Add to cart |
| 112 | $0.83 | $129.00 $92.88 (28%) | 🛒 Add to cart |
| 168 | $0.72 | $193.50 $121.26 (37%) | 🛒 Add to cart |
| 224 | $0.67
Best per pill | $258.00 $149.64 (42%) | 🛒 Add to cart |
Synonyms | |||
Mircette is a combination oral contraceptive pill designed to provide effective pregnancy prevention with a low-dose hormonal formulation. Each 28-day cycle pack contains ethinyl estradiol and desogestrel, offering a balanced approach to hormonal birth control. It is widely prescribed for its efficacy in preventing ovulation and altering cervical mucus, thereby reducing the likelihood of conception. This product is suitable for individuals seeking a convenient, daily regimen with a established safety and tolerability profile when used as directed under medical supervision.
Features
- Contains ethinyl estradiol 20 mcg and desogestrel 0.15 mg per active tablet
- 28-day blister pack with 21 active tablets and 7 inert tablets
- Monophasic formulation providing consistent hormone levels
- Small, easy-to-swallow tablets with clear day markings
- Manufactured under strict pharmaceutical quality control standards
Benefits
- Highly effective at preventing pregnancy when taken correctly
- May result in lighter, less painful menstrual periods
- Low-dose estrogen may reduce the risk of estrogen-related side effects
- Provides a regular menstrual cycle with predictable timing
- Non-contraceptive benefits may include improved acne and reduced risk of ovarian cysts
- Convenient pack design supports adherence to the daily regimen
Common use
Mircette is primarily prescribed for the prevention of pregnancy in individuals of reproductive potential. It may also be used off-label for the management of menstrual-related disorders such as dysmenorrhea or menorrhagia, though such use should be carefully evaluated by a healthcare provider based on individual patient factors and risk assessment.
Dosage and direction
Take one tablet daily at approximately the same time each day, preferably with food or at bedtime to minimize potential nausea. Begin with the first active tablet from the top row of the blister pack on the first day of menstruation or the first Sunday after menstruation begins, following provider instructions. Continue taking one tablet daily in the order indicated on the pack for 28 days, then immediately begin a new pack the following day. The seven inert tablets are included to maintain the daily habit but contain no active hormones.
Precautions
- Not protective against sexually transmitted infections
- Requires backup contraception during the first 7 days of initial use
- May affect glucose tolerance; monitor carefully in diabetic patients
- May increase blood pressure; regular monitoring recommended
- Caution advised in patients with history of depression
- Reduced efficacy may occur with gastrointestinal upset or drug interactions
- Regular breast and pelvic examinations recommended during use
Contraindications
- History of or current thrombophlebitis or thromboembolic disorders
- Cerebrovascular or coronary artery disease
- Known or suspected carcinoma of the breast or estrogen-dependent neoplasia
- Undiagnosed abnormal genital bleeding
- Known or suspected pregnancy
- Liver tumors, benign or malignant, or active liver disease
- Heavy smoking (≥15 cigarettes/day) over age 35
Possible side effects
Common side effects may include nausea, headache, breast tenderness, bloating, or mood changes, which often diminish after the first few cycles. Less frequently reported effects include changes in weight, libido, or menstrual flow patterns. Serious but rare adverse events include thrombotic disorders, hypertension, hepatic lesions, and gallbladder disease. Any unusual symptoms should be reported promptly to a healthcare provider.
Drug interaction
Mircette’s efficacy may be reduced by concomitant use of certain anticonvulsants (carbamazepine, phenytoin), barbiturates, rifampin, St. John’s wort, and some HIV medications. Broad-spectrum antibiotics may potentially decrease estrogen levels. Consult a healthcare provider about all prescription, over-the-counter, and herbal products being taken.
Missed dose
If one active tablet is missed (24-48 hours late), take it as soon as remembered and continue the schedule. If two consecutive active tablets are missed in the first two weeks, take two tablets as soon as remembered plus two tablets the next day, then resume regular schedule using backup contraception for 7 days. If two tablets are missed in the third week or three or more consecutive tablets are missed at any time, follow specific instructions provided with the prescription or contact a healthcare provider immediately.
Overdose
Nausea, vomiting, or withdrawal bleeding may occur with overdose of active tablets. There are no specific antidotes; treatment should be symptomatic and supportive. Serious effects are unlikely due to the low hormone content, but medical attention should be sought for significant ingestion, especially in children.
Storage
Store at room temperature (15-30°C or 59-86°F) in a dry place protected from light. Keep in the original packaging to maintain stability and prevent moisture damage. Keep out of reach of children and pets. Do not use tablets from damaged or compromised blister packs.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. The prescribing healthcare provider should be consulted for individual recommendations, risk assessment, and monitoring. Patients should carefully read the accompanying full prescribing information and discuss any questions or concerns with their provider.
Reviews
Clinical studies demonstrate Mircette’s high efficacy with a Pearl Index of approximately 0.4-1.2 per 100 woman-years. Patient satisfaction surveys indicate good cycle control and tolerability, particularly appreciating the low incidence of estrogen-related side effects. Healthcare providers note its suitability for patients sensitive to higher estrogen doses while maintaining contraceptive reliability. Long-term observational data support its safety profile when prescribed appropriately to eligible patients.